Results 41 to 50 of about 5,906 (249)

Hipofosforemia precoz en recién nacidos de riesgo. Frecuencia y magnitud

Anales de Pediatría, 2018
Resumen: Objetivo: Conocer la frecuencia y la magnitud de la hipofosforemia neonatal (
Gerardo Bustos Lozano, Álvaro Hidalgo Romero, Ana Melgar Bonis, Noelia Ureta Velasco, Carlos Orbea Gallardo, Carmen Pallás Alonso   +5 more
doaj   +1 more source

Seeing double: the low-carb diet [PDF]

, 2013
No abstract ...
Drummond, Russell S., Drummond, Suzannah, Lean, Michael E.J., McKenna, Louise A., Talwar, Dinesh   +4 more
core   +1 more source

Worsening of unrecognized tumour-induced osteomalacia with inadvertent use of recombinant human parathyroid hormone

Endokrynologia Polska, 2020
Not required for Clinical Vignette.
Rimesh Pal, Kanhaiya Agrawal, Setu Gupta, Anil Bhansali, Arunanshu Behera, Sanjay Kumar Bhadada   +5 more
doaj   +1 more source

Management of everolimus-associated adverse events in patients with tuberous sclerosis complex: a practical guide [PDF]

, 2017
Tuberous sclerosis complex (TSC) is a genetic disorder characterised by highly variable comorbid dysfunction and subsequent morbidity. The mTOR inhibitor everolimus is indicated for the treatment of adult TSC patients with renal angiomyolipomas (AMLs ...
Davies, Mark, Kingswood, John C., Saxena, Anurag   +2 more
core   +3 more sources

Association of hypokalaemia and hypophosphataemia [PDF]

BMJ, 1969
A prospective study of 13 patients with hypokalaemia due to a variety of causes demonstrated that six had hypophosphataemia. In 10 patients the plasma inorganic phosphate level rose on correction of the hypokalaemia. Before treatment seven patients had an excessive rate of excretion of phosphate relative to creatinine in the urine. Following correction
D C, Anderson, T J, Peters, W K, Stewart
openaire   +2 more sources

Perioperative management of patients with severe hypophosphataemia secondary to oncogenic osteomalacia: Our experience and review of literature

Indian Journal of Anaesthesia, 2017
Oncogenic osteomalacia (OOM) is a rare paraneoplastic syndrome associated with mesenchymal tumours. It is characterised by phosphaturia, hypophosphataemia, decreased serum Vitamin D3 levels and severe osteomalacia. OOM-inducing tumours are usually benign,
Alka Verma, Saipriya Tewari, Ashish Kannaujia   +2 more
doaj   +1 more source

Left Ventricular Hypertrophy in Patients with X-Linked Hypophosphataemia

JCRPE, 2022
X-linked hypophosphatemia (XLH) is a rare genetic disorder with X-linked dominant inheritance. Mutations in the PHEX gene increase fibroblast growth factor 23 (FGF23) concentrations, causing loss of phosphorus at the proximal tubule.
Ana Castellano-Martinez, Silvia Acuñas-soto, Virginia Roldan-cano, Moises Rodriguez-Gonzalez   +3 more
doaj   +1 more source

The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing-receptor (CaSR) mutation:relevance to autosomal dominant hypocalcemia type 1 (ADH1) [PDF]

, 2015
Autosomal dominant hypocalcemia type 1 (ADH1) is caused by germline gain-of-function mutations of the calcium-sensing receptor (CaSR) and may lead to symptomatic hypocalcemia, inappropriately low serum parathyroid hormone (PTH) concentrations and ...
Allen M. Spiegel, Breitwieser, Dong, Drude, Enikö Kallay, Fadil M. Hannan, Gerard V. Walls, Gowen, Hannan, Hannan, Harding, Hofer, Hough, Hu, Hu, Huang, Jianxin Hu, John, Kinoshita, Kumar, Leach, Leach, Letz, Letz, Lia-Baldini, Loupy, M. Andrew Nesbit, Miedlich, Nemeth, Nemeth, Nesbit, Pearce, Pearce, Petrel, Rajesh V. Thakker, Raue, Roger D. Cox, Stechman, Tertius A. Hough, Thim, Valerie N. Babinsky, Vargas-Poussou, Watanabe, William D. Fraser, Yamamoto   +44 more
core   +1 more source

An uncommon cause of hypophosphataemia

Australian Journal of General Practice, 2022
A woman aged 21 years underwent a diagnostic laparoscopy and appendicectomy for undifferentiated abdominal pain. She re-presented two days later with persistent fever, ongoing abdominal pain, vomiting and anorexia. At admission she was noted to be profoundly hypophosphataemic (0.21 mmol/L) with a normal corrected calcium (2.14 mmol/L).
Vardesh, Deepak L, Pandey, Sunil, Chen, Hayley   +2 more
openaire   +3 more sources

Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations [PDF]

, 2015
open9noDent disease (DD) is a rare X-linked recessive renal tubulopathy characterised by low-molecular-weight proteinuria (LMWP), hypercalciuria, nephrocalcinosis and/or nephrolithiasis. DD is caused by mutations in both the CLCN5 and OCRL genes.
Angela D’Angelo, Daniela Cremasco, Dorella Del Prete, Enrica Tosetto, Franca Anglani, Luciana Bonfante, Luisa Maria Bertizzolo, Maria Antonietta Addis, Monica Ceol, null null   +9 more
core   +2 more sources